ArticleMolecular medicine (Cambridge, Mass.)2025
Preclinical evaluation of AAV9-coSMN1 gene therapy for spinal muscular atrophy: efficacy and safety in mouse models and non-human primates.
Wenhao Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.